Compare Humana Inc (HUM) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Kraft Heinz Co — how do they compare? Humana Inc trades at $436.4 (market cap $46.49B), while Kraft Heinz Co trades at $22.07 (market cap $26.66B). The key difference: Humana Inc is the larger of the two by market cap, and Kraft Heinz Co pays the higher dividend (7.12%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Kraft Heinz Co for 129 Days on average.
| HUM | KHC | |
|---|---|---|
Market Cap | $46.49B | $26.66B |
Volume | 2,567,704 | 31,300,109 |
Sector | Health | Consumer Staples |
52-Week High | $409.85 | $27.62 |
52-Week Low | $163.67 | $21.21 |
Typical Hold Time | 53 Days | 129 Days |
Enterprise Value | $53.84B | $42.98B |
Dividend Yield | 0.91% | 7.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
Kraft Heinz (KHC) trades at $21.98, down 0.23% on the day, with a bearish technical signal and mixed fundamentals. The company reported a net loss of $5.85 billion in 2025 due to a significant impairment charge, though it has beaten EPS estimates for three consecutive quarters. Positive operating cash flow of $4.46 billion and a dividend yield near 7.3% provide some support, but high debt and declining revenue pose challenges.
The outlook remains cautious with a consensus price target of $23.78 suggesting modest upside. Risks include persistent volume declines, high leverage, and competitive pressures. The stock's deep value metrics (P/E of 13.04, P/B of 0.74) may attract contrarian investors, but sustained profitability improvement is needed for a durable rebound.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
